ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Xeris Biopharma Inc

Xeris Biopharma Inc (0A8E)

0.00
0.00
( 0.00% )

Xeris Biopharma Inc Financial Summary

The current 0A8E market cap is 0. The company's latest EPS is USD -0.4507 and P/E is -6.79.

Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 49.59M110.25M163.91M
Operating Income -115.16M-81.94M-44.01M
Net Income -122.73M-94.66M-62.26M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Assets 304.36M344.52M322.6M
Total Liabilities 209.13M299.34M329.38M
Total Equity 95.23M45.19M-6.78M

Cash Flow

Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Operating -95.54M-102.89M-47.02M
Investing 97.96M34.46M-6M
Financing 27.25M127.47M-1.61M
Market Cap 0
Price to Earnings Ratio -6.79
Price to Sales Ratio 2.58
Price to Cash Ratio 6.27
Price to Book Ratio -62.32
Dividend Yield -

Share Statistics

Shares Outstanding 138.13M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0 (0%)

Company Info

Company Name Xeris Biopharma Inc
Address corporation trust center
wilmington, delaware 19801
Website https://www.xerispharma.com
Industry pharmaceutical preparations (2834)